Search Within

Mrinal M Gounder

Formats
  1. Meeting Abstract (119)
  2. Journal Article (98)
  3. Review (4)
  4. Guidelines (2)
  5. Research Letter (2)
  6. Book Section (1)
  7. Correspondence (1)
  8. Editorial (1)
  9. Miscellaneous (1)
Groups
  1. Department of Medicine (229)
  2. Sarcoma Service (229)
  3. Solid Tumor Oncology Division (229)
  4. GSK Faculty (87)
  5. Hematologic Malignancies, Division of (85)
  6. Tow Center for Developmental Oncology (TCDO) (83)

More Groups

People
  1. William Tap (78)
  2. Mary Keohan (73)
  3. Sandra D'Angelo (73)
  4. Mark Dickson (70)
  5. Ping Chi (57)
  6. Li-Xuan Qin (52)

More People

Years
  1. 2025 (6)
  2. 2024 (17)
  3. 2023 (21)
  4. 2022 (36)
  5. 2021 (16)
  6. 2020 (25)

More Years

Publications
  1. Journal of Clinical Oncology (86)
  2. Annals of Oncology (24)
  3. Clinical Cancer Research (20)
  4. Cancer (7)
  5. The Oncologist (6)
  6. European Journal of Cancer (5)

More Publications

Publishers
  1. American Society of Clinical Oncology (88)
  2. Oxford University Press (30)
  3. American Association for Cancer Research (29)
  4. Springer (14)
  5. Elsevier Inc. (11)
  6. Nature Publishing Group (10)

More Publishers

Results (229)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outcomes of systemic therapy for patients with metastatic undifferentiated pleomorphic sarcoma (UPS)
    Meeting Abstract

    Adrianzen Herrera, D. A.; Kuk, D.; Keohan, M. L.; Dickson, M. A.; D'Angelo, S. P.; Chi, P.; Agaram, N. P.; Antonescu, C. R.; Hameed, M.; Tap, W. D.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • A phase 1 study of the MDM2 inhibitor DS-3032b in patients (pts) with advanced solid tumors and lymphomas
    Meeting Abstract

    Gounder, M. M.; Bauer, T. M.; Schwartz, G. K.; Masters, T.; Carvajal, R. D.; Song, S.; Kumar, P.; Gajee, R.; Zernovak, O.; Rosen, M. M.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • The Selinexor in Advanced Liposarcoma (SEAL) study: A phase 2/3, multicenter, randomized, double blind study of selinexor versus placebo in patients with advanced, unresectable, dedifferentiated liposarcoma (DDLS)
    Meeting Abstract

    Gounder, M. M.; Wagner, A. J.; Somaiah, N.; Riedel, R. F.; Schwartz, G. K.; Atti, S.; Razak, A. R. A.; Cranmer, L. D.; Okuno, S. H.; Milhem, M. M.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • A phase II, multicenter study of the EZH2 inhibitor tazemetostat in adult subjects with INI1-negative tumors or relapsed/refractory synovial sarcoma
    Meeting Abstract

    Agulnik, M.; Tannir, N. M.; Pressey, J. G.; Gounder, M. M.; Cote, G. M.; Roche, M.; Doleman, S.; Blakemore, S. J.; Clawson, A.; Daigle, S.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Progression-free survival among patients with well-differentiated or dedifferentiated liposarcoma treated with CDK4 inhibitor palbociclib: A phase 2 clinical trial
    Journal Article

    Dickson, M. A.; Schwartz, G. K.; Louise Keohan, M.; D'Angelo, S. P.; Gounder, M. M.; Chi, P.; Antonescu, C. R.; Landa, J.; Qin, L. X.; Crago, A. M.; more...
    JAMA Oncology (2016)

    Fulltext@MSK | Save
  • A phase I study of the MDM2 inhibitor AMG 232 in patients with advanced p53 wild type (p53WT) solid tumors or multiple myeloma
    Meeting Abstract

    Langenberg, M. H.; Gluck, L.; Weger, V.; Frank, R.; Eskens, F.; Blay, J. Y.; Soria, J. C.; Chawla, S.; Gounder, M.; Wagner, A.; more...
    European Journal of Cancer (2016)

    Fulltext@MSK | Save
  • Phase I clinical study of intratumoral injection of oncolytic Clostridium novyi-NT spores in patients with advanced cancers
    Meeting Abstract

    Janku, F.; Murthy, R.; Wang-Gillam, A.; Shepard, D.; Helgason, T.; Henry, T.; Rudin, C.; Huang, S.; Sakamuri, D.; Solomon, S.; more...
    European Journal of Cancer (2016)

    Fulltext@MSK | Save
  • A phase II, multi-center study of the EZH2 inhibitor, tazemetostat, in adult subjects with INI1-negative tumors including renal medullary carcinoma (RMC), or relapsed/refractory synovial sarcoma
    Meeting Abstract

    Tannir, N. M.; Pressey, J.; Roche, M.; Rodstrom, J.; Blakemore, S.; Clawson, A.; Daigle, S.; Gounder, M.
    BJU International (2016)

    Fulltext@MSK | Save
  • Phase IB study of selinexor, a first-in-class inhibitor of nuclear export, in patients with advanced refractory bone or soft tissue sarcoma
    Journal Article

    Gounder, M. M.; Zer, A.; Tap, W. D.; Salah, S.; Dickson, M. A.; Gupta, A. A.; Keohan, M. L.; Loong, H. H.; D'Angelo, S. P.; Baker, S.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Genomic aberrations frequently alter chromatin regulatory genes in chordoma
    Journal Article

    Wang, L.; Zehir, A.; Nafa, K.; Zhou, N.; Berger, M. F.; Casanova, J.; Sadowska, J.; Lu, C.; Allis, C. D.; Gounder, M.; more...
    Genes Chromosomes and Cancer (2016)

    Fulltext@MSK | Save